Delivery Order SPE2DB20D1100-SPE2DB24FC5Y2
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,322.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through March 5, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,140.63 delivery order contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a medical product. The contract has a performance period through December 16, 2024 and is a firm fixed-price type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,407.06, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, under a Firm Fixed Price delivery order contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ4RY, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $1,069.29 firm-fixed-price delivery order is for the supply of AMNESTEEM 20 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded multiple contracts by the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,758.32, is a Delivery Order with a Firm Fixed Price pricing type. The contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a medical product, with a period of performance through March 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,034.98, is a Firm Fixed Price Delivery Order for the supply of 4568188765 - AMNESTEEM 40 MG CAPSULE 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.85 Firm Fixed Price Delivery Order contract covers the provision of AMNESTEEM 40 MG CAPSULE 30S, a generic pharmaceutical product. The contract has an ultimate completion date of January 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $2,154.59, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2024 and was awarded on a Firm Fixed Price basis without any set-aside designation. Amerisourcebergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies...
This federal contract award, identified as SPE2DB22D1106|SPE2DB24FFEA5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,411.48, is a Firm Fixed Price Delivery Order for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, identified as SPE2DB22D1017|SPE2DB25FF0DE, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,764.62 and a period of performance through November 29, 2024. The contract is not designated as a set-aside....